| Literature DB >> 31055786 |
Masoumeh Alishahi1, Farhoodeh Ghaedrahmati2, Tannaz Akbari Kolagar1, William Winlow3,4, Negin Nikkar5, Maryam Farzaneh6, Seyed Esmaeil Khoshnam7.
Abstract
Stroke is a major cause of morbidity and mortality worldwide, and extensive efforts have focused on the improvement of therapeutic strategies to reduce cell death following ischemic stroke. Uncovering the cellular and molecular pathophysiological processes in ischemic stroke have been a top priority. Long noncoding RNAs (lncRNAs) are endogenous molecules that play key roles in the pathophysiology of cerebral ischemia, and involved in the neuronal cell death during ischemic stroke. In recent years, a bulk of aberrantly expressed lncRNAs have been screened out in ischemic stroke insulted animals. LncRNAs along with their targets could affect the genetic machinery at molecular levels, and exploring their functions and mechanisms may be a promising option for ischemic stroke treatment. In this review, we summarize the current knowledge for lncRNAs in ischemic stroke, focusing on the role of specific lncRNAs that may underlie cell death to find possible therapeutic targets.Entities:
Keywords: Cell death; Ischemic stroke; Long non-coding RNA
Mesh:
Substances:
Year: 2019 PMID: 31055786 DOI: 10.1007/s11011-019-00423-2
Source DB: PubMed Journal: Metab Brain Dis ISSN: 0885-7490 Impact factor: 3.584